142 related articles for article (PubMed ID: 73409)
1. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
Mosende C; Gutierrez M; Caparros B; Rosen G
Cancer; 1977 Dec; 40(6):2779-86. PubMed ID: 73409
[TBL] [Abstract][Full Text] [Related]
2. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
[TBL] [Abstract][Full Text] [Related]
3. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
[TBL] [Abstract][Full Text] [Related]
4. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
5. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
[TBL] [Abstract][Full Text] [Related]
6. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
Kotz R; Leber H; Ramach W; Arbes H; Wolf A
Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
[TBL] [Abstract][Full Text] [Related]
7. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
[TBL] [Abstract][Full Text] [Related]
8. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
Beattie EJ; Martini N; Rosen G
Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvant chemotherapy of malignant bone tumors].
Wilmanns W; Sauer H; Schalhorn A
Langenbecks Arch Chir; 1982; 358():393-8. PubMed ID: 6963363
[TBL] [Abstract][Full Text] [Related]
11. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy in osteogenic sarcoma: the Memorial Sloan-Kettering cancer center experience (author's transl)].
Jürgens H; Rosen G
Klin Padiatr; 1980 Mar; 192(2):123-9. PubMed ID: 6158596
[TBL] [Abstract][Full Text] [Related]
14. Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
Tefft M; Chabora BM; Rosen G
Cancer; 1977 Feb; 39(2 Suppl):806-16. PubMed ID: 402197
[TBL] [Abstract][Full Text] [Related]
15. Study of adjuvant chemotherapy in osteogenic sarcoma.
Sutow WW; Sullivan MP; Wilbur JR; Cangir A
J Clin Pharmacol; 1975 Jul; 15(7):530-3. PubMed ID: 1097476
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
17. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
[TBL] [Abstract][Full Text] [Related]
18. Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
Jürgens H; Beron G; Winkler K
J Cancer Res Clin Oncol; 1983; 106 Suppl():14-8. PubMed ID: 6350313
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
Pratt CB; Epelman S; Jaffe N
Cancer Treat Rep; 1987 Apr; 71(4):421-3. PubMed ID: 2435408
[No Abstract] [Full Text] [Related]
20. [Alternative chemotherapy of malignant bone neoplasms in children].
Jurczyk-Procyk S; Perek D
Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]